These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In vitro and In vivo evaluations of a tableted antacid and sucralfate, a new antiulcer agent. McGraw BF, Hesterlee EJ, Lanza FL, Tesler MA. Am J Gastroenterol; 1981 Nov; 76(5):412-5. PubMed ID: 6895973 [Abstract] [Full Text] [Related]
28. Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers. Krishna G, Kisicki JC, Olsen S, Grasela DM, Wang Z. Pharmacotherapy; 2007 Jul; 27(7):963-9. PubMed ID: 17594201 [Abstract] [Full Text] [Related]
37. Antiulcer activity and the mechanism of action of magaldrate in gastric ulceration models of rat. Patel AV, Santani DD, Goyal RK. Indian J Physiol Pharmacol; 2000 Jul; 44(3):350-4. PubMed ID: 10941626 [Abstract] [Full Text] [Related]
38. Effect of antacid and H2-receptor blocker treatment on gastric endocrine cells. Arnold R, Garbe I, Koop H, Mönnikes H, Schwarting H. Scand J Gastroenterol Suppl; 1984 Jul; 101():31-7. PubMed ID: 6152750 [Abstract] [Full Text] [Related]
39. [The effect of pH and amount of antacids on bile acid binding in a quasi-natural reflux milieu]. Kurtz W, Güldütuna S, Leuschner U. Z Gastroenterol; 1991 May; 29(5):237-41. PubMed ID: 1950032 [Abstract] [Full Text] [Related]
40. In vitro acid reactivity of three commercial antacid tablets. Spivey RJ, Goodhart FW. Am J Hosp Pharm; 1979 May; 36(5):660-3. PubMed ID: 36756 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]